APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sleep Disorder Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sleep Disorder Treatment Drugs Market Analysis and Forecast 2026-2032

22 December 2025215 pages

Choose your research edition.

Industry ResearchSleep Disorder Treatment Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Sleep Disorder Treatment Drugs Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Sleep Disorder Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sleep Disorder Treatment Drugs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Sleep Disorder Treatment Drugs Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Sleep Disorder Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sleep Disorder Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sleep Disorder Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sleep Disorder Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sleep Disorder Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sleep Disorder Treatment Drugs include Takeda Pharmaceutical Company, Eisai, Teva Pharmaceutical Industries Ltd., Sanofi, Merck, Pfizer, GlaxoSmithKline, ZYDUS CADILA GROUP and Natus Medicalorporated, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sleep Disorder Treatment Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sleep Disorder Treatment Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Sleep Disorder Treatment Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sleep Disorder Treatment Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sleep Disorder Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sleep Disorder Treatment Drugs sales, projected growth trends, production technology, application and end-user industry.

Sleep Disorder Treatment Drugs Segment by Company

Takeda Pharmaceutical Company

Eisai

Teva Pharmaceutical Industries Ltd.

Sanofi

Merck

Pfizer

GlaxoSmithKline

ZYDUS CADILA GROUP

Natus Medicalorporated

Mylan N.V.

Leva Pharmaceutical Industries

Koninklijke Philips

Heptares Therapeutics (Sosei Group Corporation)

Galenica

Ferring International Center

Evotec

Cardinal Health

Becton Dickson and Company

Athenex

Astellas Pharma

Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)

Sleep Disorder Treatment Drugs Segment by Type

Herbal Drugs

Prescription-based Drugs

OTC Drugs

Sleep Disorder Treatment Drugs Segment by Application

Clinics

Hospitals

Research Centers

Others

Sleep Disorder Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleep Disorder Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sleep Disorder Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleep Disorder Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sleep Disorder Treatment Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sleep Disorder Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sleep Disorder Treatment Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sleep Disorder Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Herbal Drugs Major Manufacturers Table 3. Prescription-based Drugs Major Manufacturers Table 4. OTC Drugs Major Manufacturers Table 5. Global Sleep Disorder Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinics Major Manufacturers Table 7. Hospitals Major Manufacturers Table 8. Research Centers Major Manufacturers Table 9. Others Major Manufacturers Table 10. Sleep Disorder Treatment Drugs Industry Trends Table 11. Sleep Disorder Treatment Drugs Industry Drivers Table 12. Sleep Disorder Treatment Drugs Industry Opportunities and Challenges Table 13. Sleep Disorder Treatment Drugs Industry Restraints Table 14. Global Sleep Disorder Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Sleep Disorder Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Sleep Disorder Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Sleep Disorder Treatment Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Sleep Disorder Treatment Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Sleep Disorder Treatment Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Sleep Disorder Treatment Drugs Sales by Region (2021-2026) & (k units) Table 21. Global Sleep Disorder Treatment Drugs Sales by Region (2027-2032) & (k units) Table 22. Global Sleep Disorder Treatment Drugs Sales Market Share by Region (2021-2026) Table 23. Global Sleep Disorder Treatment Drugs Sales Market Share by Region (2027-2032) Table 24. Global Sleep Disorder Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Sleep Disorder Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Sleep Disorder Treatment Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Sleep Disorder Treatment Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Sleep Disorder Treatment Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Sleep Disorder Treatment Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Sleep Disorder Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Sleep Disorder Treatment Drugs Manufacturers, Product Type & Application Table 32. Global Sleep Disorder Treatment Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Sleep Disorder Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Sleep Disorder Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Sleep Disorder Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Sleep Disorder Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Sleep Disorder Treatment Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Sleep Disorder Treatment Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Sleep Disorder Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 42. Global Sleep Disorder Treatment Drugs Sales by Type (2027-2032) & (k units) Table 43. Global Sleep Disorder Treatment Drugs Sales Market Share by Type (2021-2026) Table 44. Global Sleep Disorder Treatment Drugs Sales Market Share by Type (2027-2032) Table 45. Global Sleep Disorder Treatment Drugs Price by Type (2021-2026) & (US$/unit) Table 46. Global Sleep Disorder Treatment Drugs Price by Type (2027-2032) & (US$/unit) Table 47. Global Sleep Disorder Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sleep Disorder Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Sleep Disorder Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Sleep Disorder Treatment Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Sleep Disorder Treatment Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Sleep Disorder Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Sleep Disorder Treatment Drugs Sales by Application (2027-2032) & (k units) Table 55. Global Sleep Disorder Treatment Drugs Sales Market Share by Application (2021-2026) Table 56. Global Sleep Disorder Treatment Drugs Sales Market Share by Application (2027-2032) Table 57. Global Sleep Disorder Treatment Drugs Price by Application (2021-2026) & (US$/unit) Table 58. Global Sleep Disorder Treatment Drugs Price by Application (2027-2032) & (US$/unit) Table 59. Takeda Pharmaceutical Company Company Information Table 60. Takeda Pharmaceutical Company Business Overview Table 61. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Portfolio Table 63. Takeda Pharmaceutical Company Recent Development Table 64. Eisai Company Information Table 65. Eisai Business Overview Table 66. Eisai Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Eisai Sleep Disorder Treatment Drugs Product Portfolio Table 68. Eisai Recent Development Table 69. Teva Pharmaceutical Industries Ltd. Company Information Table 70. Teva Pharmaceutical Industries Ltd. Business Overview Table 71. Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Product Portfolio Table 73. Teva Pharmaceutical Industries Ltd. Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Sanofi Sleep Disorder Treatment Drugs Product Portfolio Table 78. Sanofi Recent Development Table 79. Merck Company Information Table 80. Merck Business Overview Table 81. Merck Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Merck Sleep Disorder Treatment Drugs Product Portfolio Table 83. Merck Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pfizer Sleep Disorder Treatment Drugs Product Portfolio Table 88. Pfizer Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Sleep Disorder Treatment Drugs Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. ZYDUS CADILA GROUP Company Information Table 95. ZYDUS CADILA GROUP Business Overview Table 96. ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Product Portfolio Table 98. ZYDUS CADILA GROUP Recent Development Table 99. Natus Medicalorporated Company Information Table 100. Natus Medicalorporated Business Overview Table 101. Natus Medicalorporated Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Natus Medicalorporated Sleep Disorder Treatment Drugs Product Portfolio Table 103. Natus Medicalorporated Recent Development Table 104. Mylan N.V. Company Information Table 105. Mylan N.V. Business Overview Table 106. Mylan N.V. Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Mylan N.V. Sleep Disorder Treatment Drugs Product Portfolio Table 108. Mylan N.V. Recent Development Table 109. Leva Pharmaceutical Industries Company Information Table 110. Leva Pharmaceutical Industries Business Overview Table 111. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Portfolio Table 113. Leva Pharmaceutical Industries Recent Development Table 114. Koninklijke Philips Company Information Table 115. Koninklijke Philips Business Overview Table 116. Koninklijke Philips Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Koninklijke Philips Sleep Disorder Treatment Drugs Product Portfolio Table 118. Koninklijke Philips Recent Development Table 119. Heptares Therapeutics (Sosei Group Corporation) Company Information Table 120. Heptares Therapeutics (Sosei Group Corporation) Business Overview Table 121. Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Product Portfolio Table 123. Heptares Therapeutics (Sosei Group Corporation) Recent Development Table 124. Galenica Company Information Table 125. Galenica Business Overview Table 126. Galenica Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Galenica Sleep Disorder Treatment Drugs Product Portfolio Table 128. Galenica Recent Development Table 129. Ferring International Center Company Information Table 130. Ferring International Center Business Overview Table 131. Ferring International Center Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Ferring International Center Sleep Disorder Treatment Drugs Product Portfolio Table 133. Ferring International Center Recent Development Table 134. Evotec Company Information Table 135. Evotec Business Overview Table 136. Evotec Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Evotec Sleep Disorder Treatment Drugs Product Portfolio Table 138. Evotec Recent Development Table 139. Cardinal Health Company Information Table 140. Cardinal Health Business Overview Table 141. Cardinal Health Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Cardinal Health Sleep Disorder Treatment Drugs Product Portfolio Table 143. Cardinal Health Recent Development Table 144. Becton Dickson and Company Company Information Table 145. Becton Dickson and Company Business Overview Table 146. Becton Dickson and Company Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Becton Dickson and Company Sleep Disorder Treatment Drugs Product Portfolio Table 148. Becton Dickson and Company Recent Development Table 149. Athenex Company Information Table 150. Athenex Business Overview Table 151. Athenex Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Athenex Sleep Disorder Treatment Drugs Product Portfolio Table 153. Athenex Recent Development Table 154. Astellas Pharma Company Information Table 155. Astellas Pharma Business Overview Table 156. Astellas Pharma Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Astellas Pharma Sleep Disorder Treatment Drugs Product Portfolio Table 158. Astellas Pharma Recent Development Table 159. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information Table 160. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Business Overview Table 161. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Product Portfolio Table 163. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Development Table 164. North America Sleep Disorder Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 165. North America Sleep Disorder Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 166. North America Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 167. North America Sleep Disorder Treatment Drugs Sales by Type (2027-2032) & (k units) Table 168. North America Sleep Disorder Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 169. North America Sleep Disorder Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 170. North America Sleep Disorder Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 171. North America Sleep Disorder Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 172. North America Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 173. North America Sleep Disorder Treatment Drugs Sales by Application (2027-2032) & (k units) Table 174. North America Sleep Disorder Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 175. North America Sleep Disorder Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 176. North America Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. North America Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. North America Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. North America Sleep Disorder Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 180. North America Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 181. North America Sleep Disorder Treatment Drugs Sales by Country (2027-2032) & (k units) Table 182. North America Sleep Disorder Treatment Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 183. North America Sleep Disorder Treatment Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 184. United States Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 185. Canada Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 186. Mexico Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 187. Europe Sleep Disorder Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 188. Europe Sleep Disorder Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 189. Europe Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 190. Europe Sleep Disorder Treatment Drugs Sales by Type (2027-2032) & (k units) Table 191. Europe Sleep Disorder Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 192. Europe Sleep Disorder Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 193. Europe Sleep Disorder Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 194. Europe Sleep Disorder Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 195. Europe Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 196. Europe Sleep Disorder Treatment Drugs Sales by Application (2027-2032) & (k units) Table 197. Europe Sleep Disorder Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 198. Europe Sleep Disorder Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 199. Europe Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Europe Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Europe Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Europe Sleep Disorder Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 203. Europe Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 204. Europe Sleep Disorder Treatment Drugs Sales by Country (2027-2032) & (k units) Table 205. Europe Sleep Disorder Treatment Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 206. Europe Sleep Disorder Treatment Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 207. Germany Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 208. France Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 209. U.K. Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 210. Italy Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 211. Russia Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 212. Spain Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 213. Netherlands Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 214. Switzerland Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 215. Sweden Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 216. Poland Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 217. China Sleep Disorder Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 218. China Sleep Disorder Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 219. China Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 220. China Sleep Disorder Treatment Drugs Sales by Type (2027-2032) & (k units) Table 221. China Sleep Disorder Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 222. China Sleep Disorder Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 223. China Sleep Disorder Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 224. China Sleep Disorder Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 225. China Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 226. China Sleep Disorder Treatment Drugs Sales by Application (2027-2032) & (k units) Table 227. China Sleep Disorder Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 228. China Sleep Disorder Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 229. Asia Sleep Disorder Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 230. Asia Sleep Disorder Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 231. Asia Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 232. Asia Sleep Disorder Treatment Drugs Sales by Type (2027-2032) & (k units) Table 233. Asia Sleep Disorder Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 234. Asia Sleep Disorder Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 235. Asia Sleep Disorder Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 236. Asia Sleep Disorder Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 237. Asia Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 238. Asia Sleep Disorder Treatment Drugs Sales by Application (2027-2032) & (k units) Table 239. Asia Sleep Disorder Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 240. Asia Sleep Disorder Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 241. Asia Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. Asia Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. Asia Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. Asia Sleep Disorder Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 245. Asia Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 246. Asia Sleep Disorder Treatment Drugs Sales by Country (2027-2032) & (k units) Table 247. Asia Sleep Disorder Treatment Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 248. Asia Sleep Disorder Treatment Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 249. Japan Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 250. South Korea Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 251. India Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 252. Australia Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 253. Taiwan Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 254. Southeast Asia Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 255. SAMEA Sleep Disorder Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 256. SAMEA Sleep Disorder Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 257. SAMEA Sleep Disorder Treatment Drugs Sales by Type (2021-2026) & (k units) Table 258. SAMEA Sleep Disorder Treatment Drugs Sales by Type (2027-2032) & (k units) Table 259. SAMEA Sleep Disorder Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 260. SAMEA Sleep Disorder Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 261. SAMEA Sleep Disorder Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 262. SAMEA Sleep Disorder Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 263. SAMEA Sleep Disorder Treatment Drugs Sales by Application (2021-2026) & (k units) Table 264. SAMEA Sleep Disorder Treatment Drugs Sales by Application (2027-2032) & (k units) Table 265. SAMEA Sleep Disorder Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 266. SAMEA Sleep Disorder Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 267. SAMEA Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 268. SAMEA Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 269. SAMEA Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 270. SAMEA Sleep Disorder Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 271. SAMEA Sleep Disorder Treatment Drugs Sales by Country (2021-2026) & (k units) Table 272. SAMEA Sleep Disorder Treatment Drugs Sales by Country (2027-2032) & (k units) Table 273. SAMEA Sleep Disorder Treatment Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 274. SAMEA Sleep Disorder Treatment Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 275. Brazil Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 276. Argentina Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 277. Chile Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 278. Colombia Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 279. Peru Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 280. Saudi Arabia Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 281. Israel Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 282. UAE Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 283. Turkey Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 284. Iran Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 285. Egypt Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 286. Key Raw Materials Table 287. Raw Materials Key Suppliers Table 288. Sleep Disorder Treatment Drugs Distributors List Table 289. Sleep Disorder Treatment Drugs Customers List Table 290. Research Programs/Design for This Report Table 291. Authors List of This Report Table 292. Secondary Sources Table 293. Primary Sources List of Figures Figure 1. Sleep Disorder Treatment Drugs Image Figure 2. Global Sleep Disorder Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sleep Disorder Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Herbal Drugs Image Figure 5. Prescription-based Drugs Image Figure 6. OTC Drugs Image Figure 7. Global Sleep Disorder Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Sleep Disorder Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinics Image Figure 10. Hospitals Image Figure 11. Research Centers Image Figure 12. Others Image Figure 13. Global Sleep Disorder Treatment Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Sleep Disorder Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Sleep Disorder Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Sleep Disorder Treatment Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Sleep Disorder Treatment Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Sleep Disorder Treatment Drugs Sales (2021-2032) & (k units) Figure 19. Global Sleep Disorder Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Sleep Disorder Treatment Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Sleep Disorder Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 22. Europe Sleep Disorder Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 23. China Sleep Disorder Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Sleep Disorder Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Sleep Disorder Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 26. Global Sleep Disorder Treatment Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Sleep Disorder Treatment Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Sleep Disorder Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Sleep Disorder Treatment Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Sleep Disorder Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Sleep Disorder Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Sleep Disorder Treatment Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Sleep Disorder Treatment Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Sleep Disorder Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Sleep Disorder Treatment Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Sleep Disorder Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Sleep Disorder Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Sleep Disorder Treatment Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Sleep Disorder Treatment Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Sleep Disorder Treatment Drugs Revenue Share by Type (2021-2032) Figure 42. North America Sleep Disorder Treatment Drugs Sales Share by Type (2021-2032) Figure 43. North America Sleep Disorder Treatment Drugs Revenue Share by Application (2021-2032) Figure 44. North America Sleep Disorder Treatment Drugs Sales Share by Application (2021-2032) Figure 45. North America Sleep Disorder Treatment Drugs Revenue Share by Country (2021-2032) Figure 46. North America Sleep Disorder Treatment Drugs Sales Share by Country (2021-2032) Figure 47. Europe Sleep Disorder Treatment Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Sleep Disorder Treatment Drugs Sales Share by Type (2021-2032) Figure 49. Europe Sleep Disorder Treatment Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Sleep Disorder Treatment Drugs Sales Share by Application (2021-2032) Figure 51. Europe Sleep Disorder Treatment Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Sleep Disorder Treatment Drugs Sales Share by Country (2021-2032) Figure 53. China Sleep Disorder Treatment Drugs Revenue Share by Type (2021-2032) Figure 54. China Sleep Disorder Treatment Drugs Sales Share by Type (2021-2032) Figure 55. China Sleep Disorder Treatment Drugs Revenue Share by Application (2021-2032) Figure 56. China Sleep Disorder Treatment Drugs Sales Share by Application (2021-2032) Figure 57. Asia Sleep Disorder Treatment Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Sleep Disorder Treatment Drugs Sales Share by Type (2021-2032) Figure 59. Asia Sleep Disorder Treatment Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Sleep Disorder Treatment Drugs Sales Share by Application (2021-2032) Figure 61. Asia Sleep Disorder Treatment Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Sleep Disorder Treatment Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Sleep Disorder Treatment Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Sleep Disorder Treatment Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Sleep Disorder Treatment Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Sleep Disorder Treatment Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Sleep Disorder Treatment Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Sleep Disorder Treatment Drugs Sales Share by Country (2021-2032) Figure 69. Sleep Disorder Treatment Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Sleep Disorder Treatment Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75.

Scope & coverage.

Types
  • Herbal Drugs
  • Prescription-based Drugs
  • OTC Drugs
Applications
  • Clinics
  • Hospitals
  • Research Centers
  • Others
Companies covered
  • Takeda Pharmaceutical Company
  • Eisai
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • ZYDUS CADILA GROUP
  • Natus Medicalorporated
  • Mylan N.V.
  • Leva Pharmaceutical Industries
  • Koninklijke Philips
  • Heptares Therapeutics (Sosei Group Corporation)
  • Galenica
  • Ferring International Center
  • Evotec
  • Cardinal Health
  • Becton Dickson and Company
  • Athenex
  • Astellas Pharma
  • Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sleep Disorder Treatment Drugs Market by Type
  3. 1.2.1 Global Sleep Disorder Treatment Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Herbal Drugs
  5. 1.2.3 Prescription-based Drugs
  6. 1.2.4 OTC Drugs
  7. 1.3 Sleep Disorder Treatment Drugs Market by Application
  8. 1.3.1 Global Sleep Disorder Treatment Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinics
  10. 1.3.3 Hospitals
  11. 1.3.4 Research Centers
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Sleep Disorder Treatment Drugs Market Dynamics
  1. 2.1 Sleep Disorder Treatment Drugs Industry Trends
  2. 2.2 Sleep Disorder Treatment Drugs Industry Drivers
  3. 2.3 Sleep Disorder Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Sleep Disorder Treatment Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sleep Disorder Treatment Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sleep Disorder Treatment Drugs Revenue by Region
  3. 3.2.1 Global Sleep Disorder Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sleep Disorder Treatment Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Sleep Disorder Treatment Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Sleep Disorder Treatment Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sleep Disorder Treatment Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sleep Disorder Treatment Drugs Sales by Region
  9. 3.4.1 Global Sleep Disorder Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sleep Disorder Treatment Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Sleep Disorder Treatment Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Sleep Disorder Treatment Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sleep Disorder Treatment Drugs Revenue by Manufacturers
  2. 4.1.1 Global Sleep Disorder Treatment Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sleep Disorder Treatment Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sleep Disorder Treatment Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sleep Disorder Treatment Drugs Sales by Manufacturers
  6. 4.2.1 Global Sleep Disorder Treatment Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sleep Disorder Treatment Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sleep Disorder Treatment Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sleep Disorder Treatment Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sleep Disorder Treatment Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sleep Disorder Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sleep Disorder Treatment Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Sleep Disorder Treatment Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sleep Disorder Treatment Drugs Market CR5 and HHI
  16. 4.8.2 2025 Sleep Disorder Treatment Drugs Tier 1, Tier 2, and Tier 3
5 Sleep Disorder Treatment Drugs Market by Type
  1. 5.1 Global Sleep Disorder Treatment Drugs Revenue by Type
  2. 5.1.1 Global Sleep Disorder Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sleep Disorder Treatment Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sleep Disorder Treatment Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sleep Disorder Treatment Drugs Sales by Type
  6. 5.2.1 Global Sleep Disorder Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sleep Disorder Treatment Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Sleep Disorder Treatment Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sleep Disorder Treatment Drugs Price by Type
6 Sleep Disorder Treatment Drugs Market by Application
  1. 6.1 Global Sleep Disorder Treatment Drugs Revenue by Application
  2. 6.1.1 Global Sleep Disorder Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sleep Disorder Treatment Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sleep Disorder Treatment Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sleep Disorder Treatment Drugs Sales by Application
  6. 6.2.1 Global Sleep Disorder Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sleep Disorder Treatment Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Sleep Disorder Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sleep Disorder Treatment Drugs Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Company
  2. 7.1.1 Takeda Pharmaceutical Company Company Information
  3. 7.1.2 Takeda Pharmaceutical Company Business Overview
  4. 7.1.3 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 7.2 Eisai
  8. 7.2.1 Eisai Company Information
  9. 7.2.2 Eisai Business Overview
  10. 7.2.3 Eisai Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eisai Sleep Disorder Treatment Drugs Product Portfolio
  12. 7.2.5 Eisai Recent Developments
  13. 7.3 Teva Pharmaceutical Industries Ltd.
  14. 7.3.1 Teva Pharmaceutical Industries Ltd. Company Information
  15. 7.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
  16. 7.3.3 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Product Portfolio
  18. 7.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  19. 7.4 Sanofi
  20. 7.4.1 Sanofi Company Information
  21. 7.4.2 Sanofi Business Overview
  22. 7.4.3 Sanofi Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Sleep Disorder Treatment Drugs Product Portfolio
  24. 7.4.5 Sanofi Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Sleep Disorder Treatment Drugs Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Sleep Disorder Treatment Drugs Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Sleep Disorder Treatment Drugs Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 ZYDUS CADILA GROUP
  44. 7.8.1 ZYDUS CADILA GROUP Company Information
  45. 7.8.2 ZYDUS CADILA GROUP Business Overview
  46. 7.8.3 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Product Portfolio
  48. 7.8.5 ZYDUS CADILA GROUP Recent Developments
  49. 7.9 Natus Medicalorporated
  50. 7.9.1 Natus Medicalorporated Company Information
  51. 7.9.2 Natus Medicalorporated Business Overview
  52. 7.9.3 Natus Medicalorporated Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Natus Medicalorporated Sleep Disorder Treatment Drugs Product Portfolio
  54. 7.9.5 Natus Medicalorporated Recent Developments
  55. 7.10 Mylan N.V.
  56. 7.10.1 Mylan N.V. Company Information
  57. 7.10.2 Mylan N.V. Business Overview
  58. 7.10.3 Mylan N.V. Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mylan N.V. Sleep Disorder Treatment Drugs Product Portfolio
  60. 7.10.5 Mylan N.V. Recent Developments
  61. 7.11 Leva Pharmaceutical Industries
  62. 7.11.1 Leva Pharmaceutical Industries Company Information
  63. 7.11.2 Leva Pharmaceutical Industries Business Overview
  64. 7.11.3 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Portfolio
  66. 7.11.5 Leva Pharmaceutical Industries Recent Developments
  67. 7.12 Koninklijke Philips
  68. 7.12.1 Koninklijke Philips Company Information
  69. 7.12.2 Koninklijke Philips Business Overview
  70. 7.12.3 Koninklijke Philips Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Koninklijke Philips Sleep Disorder Treatment Drugs Product Portfolio
  72. 7.12.5 Koninklijke Philips Recent Developments
  73. 7.13 Heptares Therapeutics (Sosei Group Corporation)
  74. 7.13.1 Heptares Therapeutics (Sosei Group Corporation) Company Information
  75. 7.13.2 Heptares Therapeutics (Sosei Group Corporation) Business Overview
  76. 7.13.3 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Product Portfolio
  78. 7.13.5 Heptares Therapeutics (Sosei Group Corporation) Recent Developments
  79. 7.14 Galenica
  80. 7.14.1 Galenica Company Information
  81. 7.14.2 Galenica Business Overview
  82. 7.14.3 Galenica Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Galenica Sleep Disorder Treatment Drugs Product Portfolio
  84. 7.14.5 Galenica Recent Developments
  85. 7.15 Ferring International Center
  86. 7.15.1 Ferring International Center Company Information
  87. 7.15.2 Ferring International Center Business Overview
  88. 7.15.3 Ferring International Center Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ferring International Center Sleep Disorder Treatment Drugs Product Portfolio
  90. 7.15.5 Ferring International Center Recent Developments
  91. 7.16 Evotec
  92. 7.16.1 Evotec Company Information
  93. 7.16.2 Evotec Business Overview
  94. 7.16.3 Evotec Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Evotec Sleep Disorder Treatment Drugs Product Portfolio
  96. 7.16.5 Evotec Recent Developments
  97. 7.17 Cardinal Health
  98. 7.17.1 Cardinal Health Company Information
  99. 7.17.2 Cardinal Health Business Overview
  100. 7.17.3 Cardinal Health Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Cardinal Health Sleep Disorder Treatment Drugs Product Portfolio
  102. 7.17.5 Cardinal Health Recent Developments
  103. 7.18 Becton Dickson and Company
  104. 7.18.1 Becton Dickson and Company Company Information
  105. 7.18.2 Becton Dickson and Company Business Overview
  106. 7.18.3 Becton Dickson and Company Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Becton Dickson and Company Sleep Disorder Treatment Drugs Product Portfolio
  108. 7.18.5 Becton Dickson and Company Recent Developments
  109. 7.19 Athenex
  110. 7.19.1 Athenex Company Information
  111. 7.19.2 Athenex Business Overview
  112. 7.19.3 Athenex Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Athenex Sleep Disorder Treatment Drugs Product Portfolio
  114. 7.19.5 Athenex Recent Developments
  115. 7.20 Astellas Pharma
  116. 7.20.1 Astellas Pharma Company Information
  117. 7.20.2 Astellas Pharma Business Overview
  118. 7.20.3 Astellas Pharma Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Astellas Pharma Sleep Disorder Treatment Drugs Product Portfolio
  120. 7.20.5 Astellas Pharma Recent Developments
  121. 7.21 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)
  122. 7.21.1 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information
  123. 7.21.2 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Business Overview
  124. 7.21.3 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Product Portfolio
  126. 7.21.5 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Developments
8 North America
  1. 8.1 North America Sleep Disorder Treatment Drugs Market Size by Type
  2. 8.1.1 North America Sleep Disorder Treatment Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Sleep Disorder Treatment Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Sleep Disorder Treatment Drugs Price by Type (2021-2032)
  5. 8.2 North America Sleep Disorder Treatment Drugs Market Size by Application
  6. 8.2.1 North America Sleep Disorder Treatment Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Sleep Disorder Treatment Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Sleep Disorder Treatment Drugs Price by Application (2021-2032)
  9. 8.3 North America Sleep Disorder Treatment Drugs Market Size by Country
  10. 8.3.1 North America Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sleep Disorder Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sleep Disorder Treatment Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Sleep Disorder Treatment Drugs Market Size by Type
  2. 9.1.1 Europe Sleep Disorder Treatment Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sleep Disorder Treatment Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Sleep Disorder Treatment Drugs Price by Type (2021-2032)
  5. 9.2 Europe Sleep Disorder Treatment Drugs Market Size by Application
  6. 9.2.1 Europe Sleep Disorder Treatment Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sleep Disorder Treatment Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Sleep Disorder Treatment Drugs Price by Application (2021-2032)
  9. 9.3 Europe Sleep Disorder Treatment Drugs Market Size by Country
  10. 9.3.1 Europe Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sleep Disorder Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sleep Disorder Treatment Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Sleep Disorder Treatment Drugs Market Size by Type
  2. 10.1.1 China Sleep Disorder Treatment Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Sleep Disorder Treatment Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Sleep Disorder Treatment Drugs Price by Type (2021-2032)
  5. 10.2 China Sleep Disorder Treatment Drugs Market Size by Application
  6. 10.2.1 China Sleep Disorder Treatment Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Sleep Disorder Treatment Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Sleep Disorder Treatment Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sleep Disorder Treatment Drugs Market Size by Type
  2. 11.1.1 Asia Sleep Disorder Treatment Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sleep Disorder Treatment Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Sleep Disorder Treatment Drugs Price by Type (2021-2032)
  5. 11.2 Asia Sleep Disorder Treatment Drugs Market Size by Application
  6. 11.2.1 Asia Sleep Disorder Treatment Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sleep Disorder Treatment Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Sleep Disorder Treatment Drugs Price by Application (2021-2032)
  9. 11.3 Asia Sleep Disorder Treatment Drugs Market Size by Country
  10. 11.3.1 Asia Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sleep Disorder Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sleep Disorder Treatment Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sleep Disorder Treatment Drugs Market Size by Type
  2. 12.1.1 SAMEA Sleep Disorder Treatment Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sleep Disorder Treatment Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sleep Disorder Treatment Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Sleep Disorder Treatment Drugs Market Size by Application
  6. 12.2.1 SAMEA Sleep Disorder Treatment Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sleep Disorder Treatment Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sleep Disorder Treatment Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Sleep Disorder Treatment Drugs Market Size by Country
  10. 12.3.1 SAMEA Sleep Disorder Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sleep Disorder Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sleep Disorder Treatment Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sleep Disorder Treatment Drugs Value Chain Analysis
  2. 13.1.1 Sleep Disorder Treatment Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sleep Disorder Treatment Drugs Production Mode & Process
  6. 13.2 Sleep Disorder Treatment Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sleep Disorder Treatment Drugs Distributors
  9. 13.2.3 Sleep Disorder Treatment Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst